Report Overview
Noninvasive cancer diagnostics and technology refer to methods and devices used to detect and diagnose cancer without the need for invasive procedures such as surgery or biopsies. These approaches aim to minimize patient discomfort, risk, and recovery time, while providing accurate and timely cancer detection.
The global Noninvasive Cancer Diagnostics and Technology market size was estimated at USD 1430 million in 2023 and is projected to reach USD 2696.08 million by 2032, exhibiting a CAGR of 7.30% during the forecast period.
North America Noninvasive Cancer Diagnostics and Technology market size was estimated at USD 420.71 million in 2023, at a CAGR of 6.26% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Noninvasive Cancer Diagnostics and Technology market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Noninvasive Cancer Diagnostics and Technology Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Noninvasive Cancer Diagnostics and Technology market in any manner.
Global Noninvasive Cancer Diagnostics and Technology Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
BIOVIEW Inc.
Affymetrix Inc.
Precision Therapeutics
Digene Corporation
A&G Pharmaceutical
Gen-Probe Incorporated
AVIVA Biosciences Corporation
Quest Diagnostics Incorporated
Laboratory Corporation of America Holdings
Guardant Health
Exact Sciences
GRAIL
Konica Minolta
Illumina
Biocept
Market Segmentation (by Type)
Immunoassays
Molecular Diagnostics
Clinical Chemistry
Other
Market Segmentation (by Application)
Medical Device Manufacturing Companies
Hospitals and Clinics
Oncology Laboratories
Private Research Institutions
Academic Institutions
Pharmaceutical Companies
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Noninvasive Cancer Diagnostics and Technology Market
Overview of the regional outlook of the Noninvasive Cancer Diagnostics and Technology Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Noninvasive Cancer Diagnostics and Technology
1.2 Key Market Segments
1.2.1 Noninvasive Cancer Diagnostics and Technology Segment by Type
1.2.2 Noninvasive Cancer Diagnostics and Technology Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Noninvasive Cancer Diagnostics and Technology Market Overview
2.1 Global Market Overview
2.1.1 Global Noninvasive Cancer Diagnostics and Technology Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Noninvasive Cancer Diagnostics and Technology Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Noninvasive Cancer Diagnostics and Technology Market Competitive Landscape
3.1 Global Noninvasive Cancer Diagnostics and Technology Sales by Manufacturers (2019-2025)
3.2 Global Noninvasive Cancer Diagnostics and Technology Revenue Market Share by Manufacturers (2019-2025)
3.3 Noninvasive Cancer Diagnostics and Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Noninvasive Cancer Diagnostics and Technology Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Noninvasive Cancer Diagnostics and Technology Sales Sites, Area Served, Product Type
3.6 Noninvasive Cancer Diagnostics and Technology Market Competitive Situation and Trends
3.6.1 Noninvasive Cancer Diagnostics and Technology Market Concentration Rate
3.6.2 Global 5 and 10 Largest Noninvasive Cancer Diagnostics and Technology Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Noninvasive Cancer Diagnostics and Technology Industry Chain Analysis
4.1 Noninvasive Cancer Diagnostics and Technology Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Noninvasive Cancer Diagnostics and Technology Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Noninvasive Cancer Diagnostics and Technology Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Noninvasive Cancer Diagnostics and Technology Sales Market Share by Type (2019-2025)
6.3 Global Noninvasive Cancer Diagnostics and Technology Market Size Market Share by Type (2019-2025)
6.4 Global Noninvasive Cancer Diagnostics and Technology Price by Type (2019-2025)
7 Noninvasive Cancer Diagnostics and Technology Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Noninvasive Cancer Diagnostics and Technology Market Sales by Application (2019-2025)
7.3 Global Noninvasive Cancer Diagnostics and Technology Market Size (M USD) by Application (2019-2025)
7.4 Global Noninvasive Cancer Diagnostics and Technology Sales Growth Rate by Application (2019-2025)
8 Noninvasive Cancer Diagnostics and Technology Market Consumption by Region
8.1 Global Noninvasive Cancer Diagnostics and Technology Sales by Region
8.1.1 Global Noninvasive Cancer Diagnostics and Technology Sales by Region
8.1.2 Global Noninvasive Cancer Diagnostics and Technology Sales Market Share by Region
8.2 North America
8.2.1 North America Noninvasive Cancer Diagnostics and Technology Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Noninvasive Cancer Diagnostics and Technology Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Noninvasive Cancer Diagnostics and Technology Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Noninvasive Cancer Diagnostics and Technology Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Noninvasive Cancer Diagnostics and Technology Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Noninvasive Cancer Diagnostics and Technology Market Production by Region
9.1 Global Production of Noninvasive Cancer Diagnostics and Technology by Region (2019-2025)
9.2 Global Noninvasive Cancer Diagnostics and Technology Revenue Market Share by Region (2019-2025)
9.3 Global Noninvasive Cancer Diagnostics and Technology Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Noninvasive Cancer Diagnostics and Technology Production
9.4.1 North America Noninvasive Cancer Diagnostics and Technology Production Growth Rate (2019-2025)
9.4.2 North America Noninvasive Cancer Diagnostics and Technology Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Noninvasive Cancer Diagnostics and Technology Production
9.5.1 Europe Noninvasive Cancer Diagnostics and Technology Production Growth Rate (2019-2025)
9.5.2 Europe Noninvasive Cancer Diagnostics and Technology Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Noninvasive Cancer Diagnostics and Technology Production (2019-2025)
9.6.1 Japan Noninvasive Cancer Diagnostics and Technology Production Growth Rate (2019-2025)
9.6.2 Japan Noninvasive Cancer Diagnostics and Technology Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Noninvasive Cancer Diagnostics and Technology Production (2019-2025)
9.7.1 China Noninvasive Cancer Diagnostics and Technology Production Growth Rate (2019-2025)
9.7.2 China Noninvasive Cancer Diagnostics and Technology Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 BIOVIEW Inc.
10.1.1 BIOVIEW Inc. Noninvasive Cancer Diagnostics and Technology Basic Information
10.1.2 BIOVIEW Inc. Noninvasive Cancer Diagnostics and Technology Product Overview
10.1.3 BIOVIEW Inc. Noninvasive Cancer Diagnostics and Technology Product Market Performance
10.1.4 BIOVIEW Inc. Business Overview
10.1.5 BIOVIEW Inc. Noninvasive Cancer Diagnostics and Technology SWOT Analysis
10.1.6 BIOVIEW Inc. Recent Developments
10.2 Affymetrix Inc.
10.2.1 Affymetrix Inc. Noninvasive Cancer Diagnostics and Technology Basic Information
10.2.2 Affymetrix Inc. Noninvasive Cancer Diagnostics and Technology Product Overview
10.2.3 Affymetrix Inc. Noninvasive Cancer Diagnostics and Technology Product Market Performance
10.2.4 Affymetrix Inc. Business Overview
10.2.5 Affymetrix Inc. Noninvasive Cancer Diagnostics and Technology SWOT Analysis
10.2.6 Affymetrix Inc. Recent Developments
10.3 Precision Therapeutics
10.3.1 Precision Therapeutics Noninvasive Cancer Diagnostics and Technology Basic Information
10.3.2 Precision Therapeutics Noninvasive Cancer Diagnostics and Technology Product Overview
10.3.3 Precision Therapeutics Noninvasive Cancer Diagnostics and Technology Product Market Performance
10.3.4 Precision Therapeutics Noninvasive Cancer Diagnostics and Technology SWOT Analysis
10.3.5 Precision Therapeutics Business Overview
10.3.6 Precision Therapeutics Recent Developments
10.4 Digene Corporation
10.4.1 Digene Corporation Noninvasive Cancer Diagnostics and Technology Basic Information
10.4.2 Digene Corporation Noninvasive Cancer Diagnostics and Technology Product Overview
10.4.3 Digene Corporation Noninvasive Cancer Diagnostics and Technology Product Market Performance
10.4.4 Digene Corporation Business Overview
10.4.5 Digene Corporation Recent Developments
10.5 AandG Pharmaceutical
10.5.1 AandG Pharmaceutical Noninvasive Cancer Diagnostics and Technology Basic Information
10.5.2 AandG Pharmaceutical Noninvasive Cancer Diagnostics and Technology Product Overview
10.5.3 AandG Pharmaceutical Noninvasive Cancer Diagnostics and Technology Product Market Performance
10.5.4 AandG Pharmaceutical Business Overview
10.5.5 AandG Pharmaceutical Recent Developments
10.6 Gen-Probe Incorporated
10.6.1 Gen-Probe Incorporated Noninvasive Cancer Diagnostics and Technology Basic Information
10.6.2 Gen-Probe Incorporated Noninvasive Cancer Diagnostics and Technology Product Overview
10.6.3 Gen-Probe Incorporated Noninvasive Cancer Diagnostics and Technology Product Market Performance
10.6.4 Gen-Probe Incorporated Business Overview
10.6.5 Gen-Probe Incorporated Recent Developments
10.7 AVIVA Biosciences Corporation
10.7.1 AVIVA Biosciences Corporation Noninvasive Cancer Diagnostics and Technology Basic Information
10.7.2 AVIVA Biosciences Corporation Noninvasive Cancer Diagnostics and Technology Product Overview
10.7.3 AVIVA Biosciences Corporation Noninvasive Cancer Diagnostics and Technology Product Market Performance
10.7.4 AVIVA Biosciences Corporation Business Overview
10.7.5 AVIVA Biosciences Corporation Recent Developments
10.8 Quest Diagnostics Incorporated
10.8.1 Quest Diagnostics Incorporated Noninvasive Cancer Diagnostics and Technology Basic Information
10.8.2 Quest Diagnostics Incorporated Noninvasive Cancer Diagnostics and Technology Product Overview
10.8.3 Quest Diagnostics Incorporated Noninvasive Cancer Diagnostics and Technology Product Market Performance
10.8.4 Quest Diagnostics Incorporated Business Overview
10.8.5 Quest Diagnostics Incorporated Recent Developments
10.9 Laboratory Corporation of America Holdings
10.9.1 Laboratory Corporation of America Holdings Noninvasive Cancer Diagnostics and Technology Basic Information
10.9.2 Laboratory Corporation of America Holdings Noninvasive Cancer Diagnostics and Technology Product Overview
10.9.3 Laboratory Corporation of America Holdings Noninvasive Cancer Diagnostics and Technology Product Market Performance
10.9.4 Laboratory Corporation of America Holdings Business Overview
10.9.5 Laboratory Corporation of America Holdings Recent Developments
10.10 Guardant Health
10.10.1 Guardant Health Noninvasive Cancer Diagnostics and Technology Basic Information
10.10.2 Guardant Health Noninvasive Cancer Diagnostics and Technology Product Overview
10.10.3 Guardant Health Noninvasive Cancer Diagnostics and Technology Product Market Performance
10.10.4 Guardant Health Business Overview
10.10.5 Guardant Health Recent Developments
10.11 Exact Sciences
10.11.1 Exact Sciences Noninvasive Cancer Diagnostics and Technology Basic Information
10.11.2 Exact Sciences Noninvasive Cancer Diagnostics and Technology Product Overview
10.11.3 Exact Sciences Noninvasive Cancer Diagnostics and Technology Product Market Performance
10.11.4 Exact Sciences Business Overview
10.11.5 Exact Sciences Recent Developments
10.12 GRAIL
10.12.1 GRAIL Noninvasive Cancer Diagnostics and Technology Basic Information
10.12.2 GRAIL Noninvasive Cancer Diagnostics and Technology Product Overview
10.12.3 GRAIL Noninvasive Cancer Diagnostics and Technology Product Market Performance
10.12.4 GRAIL Business Overview
10.12.5 GRAIL Recent Developments
10.13 Konica Minolta
10.13.1 Konica Minolta Noninvasive Cancer Diagnostics and Technology Basic Information
10.13.2 Konica Minolta Noninvasive Cancer Diagnostics and Technology Product Overview
10.13.3 Konica Minolta Noninvasive Cancer Diagnostics and Technology Product Market Performance
10.13.4 Konica Minolta Business Overview
10.13.5 Konica Minolta Recent Developments
10.14 Illumina
10.14.1 Illumina Noninvasive Cancer Diagnostics and Technology Basic Information
10.14.2 Illumina Noninvasive Cancer Diagnostics and Technology Product Overview
10.14.3 Illumina Noninvasive Cancer Diagnostics and Technology Product Market Performance
10.14.4 Illumina Business Overview
10.14.5 Illumina Recent Developments
10.15 Biocept
10.15.1 Biocept Noninvasive Cancer Diagnostics and Technology Basic Information
10.15.2 Biocept Noninvasive Cancer Diagnostics and Technology Product Overview
10.15.3 Biocept Noninvasive Cancer Diagnostics and Technology Product Market Performance
10.15.4 Biocept Business Overview
10.15.5 Biocept Recent Developments
11 Noninvasive Cancer Diagnostics and Technology Market Forecast by Region
11.1 Global Noninvasive Cancer Diagnostics and Technology Market Size Forecast
11.2 Global Noninvasive Cancer Diagnostics and Technology Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Noninvasive Cancer Diagnostics and Technology Market Size Forecast by Country
11.2.3 Asia Pacific Noninvasive Cancer Diagnostics and Technology Market Size Forecast by Region
11.2.4 South America Noninvasive Cancer Diagnostics and Technology Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Noninvasive Cancer Diagnostics and Technology by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Noninvasive Cancer Diagnostics and Technology Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Noninvasive Cancer Diagnostics and Technology by Type (2025-2032)
12.1.2 Global Noninvasive Cancer Diagnostics and Technology Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Noninvasive Cancer Diagnostics and Technology by Type (2025-2032)
12.2 Global Noninvasive Cancer Diagnostics and Technology Market Forecast by Application (2025-2032)
12.2.1 Global Noninvasive Cancer Diagnostics and Technology Sales (K Units) Forecast by Application
12.2.2 Global Noninvasive Cancer Diagnostics and Technology Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Noninvasive Cancer Diagnostics and Technology Market Size Comparison by Region (M USD)
Table 5. Global Noninvasive Cancer Diagnostics and Technology Sales (K Units) by Manufacturers (2019-2025)
Table 6. Global Noninvasive Cancer Diagnostics and Technology Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Noninvasive Cancer Diagnostics and Technology Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Noninvasive Cancer Diagnostics and Technology Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Noninvasive Cancer Diagnostics and Technology as of 2022)
Table 10. Global Market Noninvasive Cancer Diagnostics and Technology Average Price (USD/Unit) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Noninvasive Cancer Diagnostics and Technology Sales Sites and Area Served
Table 12. Manufacturers Noninvasive Cancer Diagnostics and Technology Product Type
Table 13. Global Noninvasive Cancer Diagnostics and Technology Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Noninvasive Cancer Diagnostics and Technology
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Noninvasive Cancer Diagnostics and Technology Market Challenges
Table 22. Global Noninvasive Cancer Diagnostics and Technology Sales by Type (K Units)
Table 23. Global Noninvasive Cancer Diagnostics and Technology Market Size by Type (M USD)
Table 24. Global Noninvasive Cancer Diagnostics and Technology Sales (K Units) by Type (2019-2025)
Table 25. Global Noninvasive Cancer Diagnostics and Technology Sales Market Share by Type (2019-2025)
Table 26. Global Noninvasive Cancer Diagnostics and Technology Market Size (M USD) by Type (2019-2025)
Table 27. Global Noninvasive Cancer Diagnostics and Technology Market Size Share by Type (2019-2025)
Table 28. Global Noninvasive Cancer Diagnostics and Technology Price (USD/Unit) by Type (2019-2025)
Table 29. Global Noninvasive Cancer Diagnostics and Technology Sales (K Units) by Application
Table 30. Global Noninvasive Cancer Diagnostics and Technology Market Size by Application
Table 31. Global Noninvasive Cancer Diagnostics and Technology Sales by Application (2019-2025) & (K Units)
Table 32. Global Noninvasive Cancer Diagnostics and Technology Sales Market Share by Application (2019-2025)
Table 33. Global Noninvasive Cancer Diagnostics and Technology Sales by Application (2019-2025) & (M USD)
Table 34. Global Noninvasive Cancer Diagnostics and Technology Market Share by Application (2019-2025)
Table 35. Global Noninvasive Cancer Diagnostics and Technology Sales Growth Rate by Application (2019-2025)
Table 36. Global Noninvasive Cancer Diagnostics and Technology Sales by Region (2019-2025) & (K Units)
Table 37. Global Noninvasive Cancer Diagnostics and Technology Sales Market Share by Region (2019-2025)
Table 38. North America Noninvasive Cancer Diagnostics and Technology Sales by Country (2019-2025) & (K Units)
Table 39. Europe Noninvasive Cancer Diagnostics and Technology Sales by Country (2019-2025) & (K Units)
Table 40. Asia Pacific Noninvasive Cancer Diagnostics and Technology Sales by Region (2019-2025) & (K Units)
Table 41. South America Noninvasive Cancer Diagnostics and Technology Sales by Country (2019-2025) & (K Units)
Table 42. Middle East and Africa Noninvasive Cancer Diagnostics and Technology Sales by Region (2019-2025) & (K Units)
Table 43. Global Noninvasive Cancer Diagnostics and Technology Production (K Units) by Region (2019-2025)
Table 44. Global Noninvasive Cancer Diagnostics and Technology Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Noninvasive Cancer Diagnostics and Technology Revenue Market Share by Region (2019-2025)
Table 46. Global Noninvasive Cancer Diagnostics and Technology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 47. North America Noninvasive Cancer Diagnostics and Technology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 48. Europe Noninvasive Cancer Diagnostics and Technology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 49. Japan Noninvasive Cancer Diagnostics and Technology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 50. China Noninvasive Cancer Diagnostics and Technology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 51. BIOVIEW Inc. Noninvasive Cancer Diagnostics and Technology Basic Information
Table 52. BIOVIEW Inc. Noninvasive Cancer Diagnostics and Technology Product Overview
Table 53. BIOVIEW Inc. Noninvasive Cancer Diagnostics and Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 54. BIOVIEW Inc. Business Overview
Table 55. BIOVIEW Inc. Noninvasive Cancer Diagnostics and Technology SWOT Analysis
Table 56. BIOVIEW Inc. Recent Developments
Table 57. Affymetrix Inc. Noninvasive Cancer Diagnostics and Technology Basic Information
Table 58. Affymetrix Inc. Noninvasive Cancer Diagnostics and Technology Product Overview
Table 59. Affymetrix Inc. Noninvasive Cancer Diagnostics and Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 60. Affymetrix Inc. Business Overview
Table 61. Affymetrix Inc. Noninvasive Cancer Diagnostics and Technology SWOT Analysis
Table 62. Affymetrix Inc. Recent Developments
Table 63. Precision Therapeutics Noninvasive Cancer Diagnostics and Technology Basic Information
Table 64. Precision Therapeutics Noninvasive Cancer Diagnostics and Technology Product Overview
Table 65. Precision Therapeutics Noninvasive Cancer Diagnostics and Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 66. Precision Therapeutics Noninvasive Cancer Diagnostics and Technology SWOT Analysis
Table 67. Precision Therapeutics Business Overview
Table 68. Precision Therapeutics Recent Developments
Table 69. Digene Corporation Noninvasive Cancer Diagnostics and Technology Basic Information
Table 70. Digene Corporation Noninvasive Cancer Diagnostics and Technology Product Overview
Table 71. Digene Corporation Noninvasive Cancer Diagnostics and Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 72. Digene Corporation Business Overview
Table 73. Digene Corporation Recent Developments
Table 74. AandG Pharmaceutical Noninvasive Cancer Diagnostics and Technology Basic Information
Table 75. AandG Pharmaceutical Noninvasive Cancer Diagnostics and Technology Product Overview
Table 76. AandG Pharmaceutical Noninvasive Cancer Diagnostics and Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 77. AandG Pharmaceutical Business Overview
Table 78. AandG Pharmaceutical Recent Developments
Table 79. Gen-Probe Incorporated Noninvasive Cancer Diagnostics and Technology Basic Information
Table 80. Gen-Probe Incorporated Noninvasive Cancer Diagnostics and Technology Product Overview
Table 81. Gen-Probe Incorporated Noninvasive Cancer Diagnostics and Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 82. Gen-Probe Incorporated Business Overview
Table 83. Gen-Probe Incorporated Recent Developments
Table 84. AVIVA Biosciences Corporation Noninvasive Cancer Diagnostics and Technology Basic Information
Table 85. AVIVA Biosciences Corporation Noninvasive Cancer Diagnostics and Technology Product Overview
Table 86. AVIVA Biosciences Corporation Noninvasive Cancer Diagnostics and Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 87. AVIVA Biosciences Corporation Business Overview
Table 88. AVIVA Biosciences Corporation Recent Developments
Table 89. Quest Diagnostics Incorporated Noninvasive Cancer Diagnostics and Technology Basic Information
Table 90. Quest Diagnostics Incorporated Noninvasive Cancer Diagnostics and Technology Product Overview
Table 91. Quest Diagnostics Incorporated Noninvasive Cancer Diagnostics and Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 92. Quest Diagnostics Incorporated Business Overview
Table 93. Quest Diagnostics Incorporated Recent Developments
Table 94. Laboratory Corporation of America Holdings Noninvasive Cancer Diagnostics and Technology Basic Information
Table 95. Laboratory Corporation of America Holdings Noninvasive Cancer Diagnostics and Technology Product Overview
Table 96. Laboratory Corporation of America Holdings Noninvasive Cancer Diagnostics and Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 97. Laboratory Corporation of America Holdings Business Overview
Table 98. Laboratory Corporation of America Holdings Recent Developments
Table 99. Guardant Health Noninvasive Cancer Diagnostics and Technology Basic Information
Table 100. Guardant Health Noninvasive Cancer Diagnostics and Technology Product Overview
Table 101. Guardant Health Noninvasive Cancer Diagnostics and Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 102. Guardant Health Business Overview
Table 103. Guardant Health Recent Developments
Table 104. Exact Sciences Noninvasive Cancer Diagnostics and Technology Basic Information
Table 105. Exact Sciences Noninvasive Cancer Diagnostics and Technology Product Overview
Table 106. Exact Sciences Noninvasive Cancer Diagnostics and Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 107. Exact Sciences Business Overview
Table 108. Exact Sciences Recent Developments
Table 109. GRAIL Noninvasive Cancer Diagnostics and Technology Basic Information
Table 110. GRAIL Noninvasive Cancer Diagnostics and Technology Product Overview
Table 111. GRAIL Noninvasive Cancer Diagnostics and Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 112. GRAIL Business Overview
Table 113. GRAIL Recent Developments
Table 114. Konica Minolta Noninvasive Cancer Diagnostics and Technology Basic Information
Table 115. Konica Minolta Noninvasive Cancer Diagnostics and Technology Product Overview
Table 116. Konica Minolta Noninvasive Cancer Diagnostics and Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 117. Konica Minolta Business Overview
Table 118. Konica Minolta Recent Developments
Table 119. Illumina Noninvasive Cancer Diagnostics and Technology Basic Information
Table 120. Illumina Noninvasive Cancer Diagnostics and Technology Product Overview
Table 121. Illumina Noninvasive Cancer Diagnostics and Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 122. Illumina Business Overview
Table 123. Illumina Recent Developments
Table 124. Biocept Noninvasive Cancer Diagnostics and Technology Basic Information
Table 125. Biocept Noninvasive Cancer Diagnostics and Technology Product Overview
Table 126. Biocept Noninvasive Cancer Diagnostics and Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 127. Biocept Business Overview
Table 128. Biocept Recent Developments
Table 129. Global Noninvasive Cancer Diagnostics and Technology Sales Forecast by Region (2025-2032) & (K Units)
Table 130. Global Noninvasive Cancer Diagnostics and Technology Market Size Forecast by Region (2025-2032) & (M USD)
Table 131. North America Noninvasive Cancer Diagnostics and Technology Sales Forecast by Country (2025-2032) & (K Units)
Table 132. North America Noninvasive Cancer Diagnostics and Technology Market Size Forecast by Country (2025-2032) & (M USD)
Table 133. Europe Noninvasive Cancer Diagnostics and Technology Sales Forecast by Country (2025-2032) & (K Units)
Table 134. Europe Noninvasive Cancer Diagnostics and Technology Market Size Forecast by Country (2025-2032) & (M USD)
Table 135. Asia Pacific Noninvasive Cancer Diagnostics and Technology Sales Forecast by Region (2025-2032) & (K Units)
Table 136. Asia Pacific Noninvasive Cancer Diagnostics and Technology Market Size Forecast by Region (2025-2032) & (M USD)
Table 137. South America Noninvasive Cancer Diagnostics and Technology Sales Forecast by Country (2025-2032) & (K Units)
Table 138. South America Noninvasive Cancer Diagnostics and Technology Market Size Forecast by Country (2025-2032) & (M USD)
Table 139. Middle East and Africa Noninvasive Cancer Diagnostics and Technology Consumption Forecast by Country (2025-2032) & (Units)
Table 140. Middle East and Africa Noninvasive Cancer Diagnostics and Technology Market Size Forecast by Country (2025-2032) & (M USD)
Table 141. Global Noninvasive Cancer Diagnostics and Technology Sales Forecast by Type (2025-2032) & (K Units)
Table 142. Global Noninvasive Cancer Diagnostics and Technology Market Size Forecast by Type (2025-2032) & (M USD)
Table 143. Global Noninvasive Cancer Diagnostics and Technology Price Forecast by Type (2025-2032) & (USD/Unit)
Table 144. Global Noninvasive Cancer Diagnostics and Technology Sales (K Units) Forecast by Application (2025-2032)
Table 145. Global Noninvasive Cancer Diagnostics and Technology Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Noninvasive Cancer Diagnostics and Technology
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Noninvasive Cancer Diagnostics and Technology Market Size (M USD), 2019-2032
Figure 5. Global Noninvasive Cancer Diagnostics and Technology Market Size (M USD) (2019-2032)
Figure 6. Global Noninvasive Cancer Diagnostics and Technology Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Noninvasive Cancer Diagnostics and Technology Market Size by Country (M USD)
Figure 11. Noninvasive Cancer Diagnostics and Technology Sales Share by Manufacturers in 2023
Figure 12. Global Noninvasive Cancer Diagnostics and Technology Revenue Share by Manufacturers in 2023
Figure 13. Noninvasive Cancer Diagnostics and Technology Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Noninvasive Cancer Diagnostics and Technology Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Noninvasive Cancer Diagnostics and Technology Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Noninvasive Cancer Diagnostics and Technology Market Share by Type
Figure 18. Sales Market Share of Noninvasive Cancer Diagnostics and Technology by Type (2019-2025)
Figure 19. Sales Market Share of Noninvasive Cancer Diagnostics and Technology by Type in 2023
Figure 20. Market Size Share of Noninvasive Cancer Diagnostics and Technology by Type (2019-2025)
Figure 21. Market Size Market Share of Noninvasive Cancer Diagnostics and Technology by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Noninvasive Cancer Diagnostics and Technology Market Share by Application
Figure 24. Global Noninvasive Cancer Diagnostics and Technology Sales Market Share by Application (2019-2025)
Figure 25. Global Noninvasive Cancer Diagnostics and Technology Sales Market Share by Application in 2023
Figure 26. Global Noninvasive Cancer Diagnostics and Technology Market Share by Application (2019-2025)
Figure 27. Global Noninvasive Cancer Diagnostics and Technology Market Share by Application in 2023
Figure 28. Global Noninvasive Cancer Diagnostics and Technology Sales Growth Rate by Application (2019-2025)
Figure 29. Global Noninvasive Cancer Diagnostics and Technology Sales Market Share by Region (2019-2025)
Figure 30. North America Noninvasive Cancer Diagnostics and Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 31. North America Noninvasive Cancer Diagnostics and Technology Sales Market Share by Country in 2023
Figure 32. U.S. Noninvasive Cancer Diagnostics and Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 33. Canada Noninvasive Cancer Diagnostics and Technology Sales (K Units) and Growth Rate (2019-2025)
Figure 34. Mexico Noninvasive Cancer Diagnostics and Technology Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Noninvasive Cancer Diagnostics and Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 36. Europe Noninvasive Cancer Diagnostics and Technology Sales Market Share by Country in 2023
Figure 37. Germany Noninvasive Cancer Diagnostics and Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 38. France Noninvasive Cancer Diagnostics and Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 39. U.K. Noninvasive Cancer Diagnostics and Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 40. Italy Noninvasive Cancer Diagnostics and Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 41. Russia Noninvasive Cancer Diagnostics and Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 42. Asia Pacific Noninvasive Cancer Diagnostics and Technology Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Noninvasive Cancer Diagnostics and Technology Sales Market Share by Region in 2023
Figure 44. China Noninvasive Cancer Diagnostics and Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 45. Japan Noninvasive Cancer Diagnostics and Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 46. South Korea Noninvasive Cancer Diagnostics and Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 47. India Noninvasive Cancer Diagnostics and Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 48. Southeast Asia Noninvasive Cancer Diagnostics and Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 49. South America Noninvasive Cancer Diagnostics and Technology Sales and Growth Rate (K Units)
Figure 50. South America Noninvasive Cancer Diagnostics and Technology Sales Market Share by Country in 2023
Figure 51. Brazil Noninvasive Cancer Diagnostics and Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 52. Argentina Noninvasive Cancer Diagnostics and Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 53. Columbia Noninvasive Cancer Diagnostics and Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 54. Middle East and Africa Noninvasive Cancer Diagnostics and Technology Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Noninvasive Cancer Diagnostics and Technology Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Noninvasive Cancer Diagnostics and Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 57. UAE Noninvasive Cancer Diagnostics and Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 58. Egypt Noninvasive Cancer Diagnostics and Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 59. Nigeria Noninvasive Cancer Diagnostics and Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 60. South Africa Noninvasive Cancer Diagnostics and Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 61. Global Noninvasive Cancer Diagnostics and Technology Production Market Share by Region (2019-2025)
Figure 62. North America Noninvasive Cancer Diagnostics and Technology Production (K Units) Growth Rate (2019-2025)
Figure 63. Europe Noninvasive Cancer Diagnostics and Technology Production (K Units) Growth Rate (2019-2025)
Figure 64. Japan Noninvasive Cancer Diagnostics and Technology Production (K Units) Growth Rate (2019-2025)
Figure 65. China Noninvasive Cancer Diagnostics and Technology Production (K Units) Growth Rate (2019-2025)
Figure 66. Global Noninvasive Cancer Diagnostics and Technology Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Noninvasive Cancer Diagnostics and Technology Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Noninvasive Cancer Diagnostics and Technology Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Noninvasive Cancer Diagnostics and Technology Market Share Forecast by Type (2025-2032)
Figure 70. Global Noninvasive Cancer Diagnostics and Technology Sales Forecast by Application (2025-2032)
Figure 71. Global Noninvasive Cancer Diagnostics and Technology Market Share Forecast by Application (2025-2032)
